Ratings NEXTEDIA

Equities

ALNXT

FR0004171346

Market Closed - Euronext Paris 10:28:53 2024-04-26 am EDT 5-day change 1st Jan Change
0.64 EUR +0.63% Intraday chart for NEXTEDIA -4.19% +10.34%

Strengths

  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • With a P/E ratio at 10.67 for the current year and 8 for next year, earnings multiples are highly attractive compared with competitors.
  • The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.35 for the 2024 fiscal year.
  • The company has a low valuation given the cash flows generated by its activity.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • The group usually releases upbeat results with huge surprise rates.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company does not generate enough profits, which is an alarming weak point.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.

Ratings chart - Surperformance

Sector: IT Services & Consulting

1st Jan change Capi. Investor Rating ESG Refinitiv
+10.34% 26.65M -
-12.23% 194B
A-
+0.74% 166B
B+
+2.19% 153B
B-
+4.34% 99.85B
A-
+7.04% 77.56B
A-
+19.09% 73.55B
C-
-7.30% 71B
A
-20.54% 52.81B
C
+0.53% 47.86B
A-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes